Package 69097-811-12

{"route": ["ORAL"], "spl_id": "69887d93-de9a-4397-a629-a0ce8e62c69a", "openfda": {"nui": ["N0000008486"], "upc": ["0369097812072", "0369097811075"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["7c3ac86f-b8f7-42bf-942a-db854d946e54"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-811-02)", "package_ndc": "69097-811-02", "marketing_start_date": "20160722"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-811-07)", "package_ndc": "69097-811-07", "marketing_start_date": "20160722"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69097-811-12)", "package_ndc": "69097-811-12", "marketing_start_date": "20160722"}], "brand_name": "Gabapentin", "product_id": "69097-811_69887d93-de9a-4397-a629-a0ce8e62c69a", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69097-811", "generic_name": "Gabapentin", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA202764", "marketing_category": "ANDA", "marketing_start_date": "20160722", "listing_expiration_date": "20261231"}